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Background: Schistosomiasis is a chronic disease caused by trematode flatworms of the genus Schistosoma. The
disease remains a serious public health problem in endemic countries and affects at least 207 million people
worldwide. A definite diagnosis of the disease plays a key role in the control of schistosomiasis. The detection of
schistosome circulating antigens (CAs) is an effective approach to discriminate between previous exposure and
current infection. Different methods have been investigated for detecting the CAs. However, the components of
the schistosome CAs remain unclear. In this study, we analyzed the CAs in sera of patients infected with
Schistosoma japonicum.
Methods: The parasites were collected from the infected rabbits for preparing the adult worm antigen (AWA).
The hyline hens were immunized subcutaneously with AWA to produce anti-AWA IgY. The IgY was purified
by water-dilution and ammonium sulfate precipitation method and identified by ELISA and Western blotting.
After purification and characterization, IgY was immobilized onto the resin as a capture antibody. The
circulating antigens were immune-precipitated from patients′ serum samples by direct immunoprecipitation.
The precipitated proteins were separated by one-dimensional electrophoresis and analyzed by LC-MS/MS.
Results: Firstly, the IgY against AWA was produced from the eggs of immunized hens by AWA, which gave a
titer of 1:12800. The purified IgY was used as the capture antibody to enrich the CAs in sera of S. japonicum
infected patients through immunoprecipitation. The CAs were determined by LC-MS/MS. There were four
proteins, including protein BUD31 homolog, ribonuclease, SJCHGC06971 protein and SJCHGC04754 protein,
which were identified among the CAs.
Conclusions: We developed a novel method based on IgY for identification and profiling CAs in sera of S.
japonicum infected patients. Four new CAs were identified and have potential value for further development
of an antigen assay.
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Schistosomiasis, also known as Bilharziasis, is a parasitic
disease caused by trematode flatworms of the genus Schis-
tosoma. Larval forms of the parasite, which are released by
freshwater snails, penetrate the skin of the definitive hosts,
human or other mammals when contacting the infested
water [1-3]. Approximately 207 million people were* Correspondence: xnwang88@gmail.com; huwwyz@163.com
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reproduction in any medium, provided the orestimated to be infected with schistosomiasis, and
close to 800 million people were at risk of infection
[4]. Schistosomiasis causes significant morbidity and
mortality in developing countries. A meta-analysis
assigned 2-15% disability weight associated with
chronic schistosome infection [5].
Sensitive diagnoses, monitoring of the disease transmis-
sion and evaluation of chemotherapeutic interventions, are
of primary importance for the improvement of control and
prevention strategies for schistosomiasis [6]. Schistosomia-
sis can be diagnosed by direct or indirect methods: a) directThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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urine samples or in the tissues; b) direct approaches to de-
tect the schistosome-derived antigens in the circulation and
excreta; c) indirect immunological tests to detect the spe-
cific antibodies induced against the different stages of the
parasite in blood [7,8]. Direct parasitological diagnosis tech-
niques are labor-intensive and time-consuming. Moreover,
their low sensitivities would result in under-estimation in
prevalence and infection intensity, particularly in the areas
with low prevalence or after intervention [9,10]. Immuno-
logical diagnoses are applied most widely to detect the anti-
bodies due to a higher sensitivity. However, antibody-based
serological assays do not discriminate between active and
past infections, and thus could not be used to evaluate
therapeutic efficacy since specific antibodies continue to be
present for a long time after the worms have disappeared
[10,11].
Therefore, detection of circulating antigens has been
used for the diagnosis of schistosomiasis because these
antigens could be demonstrated in the circulation and
excreta of infected individuals and the antigen levels
have been found to correlate well with parasitic load
[12,13]. This method has proved to be an effective way
to assess the active infections and the effects of treat-
ments in endemic areas with high sensitivity and specifi-
city [7,14,15]. Furthermore, detection of these antigens
has provided a valuable tool for population screening,
and to study the sero-epidemiology of the disease
[16,17]. A test has been developed to detect circulating
cathodic antigen (CCA) in urine for the diagnosis of
Schistosoma mansoni as a rapid diagnostic test in cas-
sette form. Although the assay shows similar sensitivity
to the Kato-Katz method for S. mansoni diagnosis, it is
still an attractive tool due to its fast and easy application
for the large-scale screening in control programs [18,19].
Moreover, a sandwich time-resolved fluoroimmunoassay
(TRFIA) for detecting the circulating antigen 14-3-3 of
S. japonicum in rabbits could reach higher positive rates
compared to ELISA within the first 21 days post-
infection. It is demonstrated to be a good early diagnos-
tic method for active schistosome infection [20].
According to the different developmental stages of the
schistosome, the circulating antigens can be classified
into cercarial antigens, adult worm associated antigens
(e.g. tegument or gut-associated), and egg antigens [7].
The major circulating antigens belong to the group of
the adult worm gut-associated circulating antigens.
These antigens are released into the circulation of the
host at regular time intervals from the gut of adult schis-
tosomes [7,21]. So far, most research has focused on the
circulating anodic antigen (CAA) and the circulating
cathodic antigen (CCA) [22-27]. In addition to CAA and
CCA, few of the other circulating antigens have been
characterized.We intend to characterize more circulating antigens
by a new method based on egg yolk immunoglobulin
(IgY). The IgY has been recognized as an alternative
source of polyclonal antibodies. The use of chicken IgY
instead of mammalian antibodies brings great benefit
concerning the welfare of the immunized animals, due
to non-invasive antibody harvesting with the added con-
venience of simple egg collection. An additional advan-
tage is the fast and simple IgY isolation from egg yolk
[28]. In addition, IgY do not activate the mammalian
complement system [29], or bind to rheumatoid factors
(RF) [30], or show interaction with human and bacterial
Fc receptors [31,32]. Because of these advantages, IgY
has been used for diagnosis in different diseases [33-35].
Recently, a novel immunomagnetic bead ELISA using IgY
against SEA as a capture antibody (IgY-IMB-ELISA) was
applied to detect CAs in sera of murine schistosomiasis
and the serum samples of persons with schistosomiasis.
This method appeared to be sensitive and specific by using
100μl serum samples for diagnosis of schistosome infec-
tion and also valuable in judging the efficacy of chemo-
therapy in schistosomiasis [36,37].
In the present study, we used IgY as the capture anti-
body to concentrate the circulating antigens in the sera
of schistosomiasis japonica patients through immuno-
precipitation. Then the antigens were identified by liquid
chromatography-tandem mass spectrometry (LC-MS/MS).
This was the first study for profiling CAs of S. japonicum,
the findings of which might be of informative significance




Each laboratory rabbit (Oryctolagus cuniculus) was per-
cutaneously infected with 1000 S. japonicum cercariae
isolated from the infected Oncomelania hupensis snails
in the field. After challenge infection, the adult worms
were collected by perfusing the hepatic portal system
and mesenteric veins of the rabbits at 42 days post infec-
tion. The worms were washed at least three times with
normal saline to remove the host tissues [38].
Antigen preparation
Briefly, adult S. japonicum worms (Chinese strain) were
suspended in the buffer (10 mM KCl, 10 mM Tris-Cl
pH7.5, 1 mM EDTA, 10nM β-mercaptoethanol, 5 mM
DTT, 20% glycerol), homogenized with a tissue grinder,
frozen and thawed three times, and then sonicated with
three cycles at 100 Hz for 60 seconds each [39,40].
The antigen solution was a homogenate including the
total soluble proteins and insoluble proteins of adult
worm. The concentration of the suspension was deter-
mined by Bradford protein assay kit (TIANGEN, China)
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pared adult worm antigen (AWA) obtained was ali-
quoted and stored at −20°C until use.
Preparation and characterization of IgY
AWA was formulated with 2 volumes of either Freund
complete (prime) or Freund incomplete (two boost) ad-
juvant. 28-week-old hyline hens were immunized sub-
cutaneously with AWA four times at an interval of
14 days with a dose of 0.5 ml (1.8 mg protein), while the
AWA in PBS was used for the last immunization. The
hens were maintained in a standard SPF (specific
pathogen-free) condition. Chicken eggs were collected
daily before immunization and 7 days after the last
immunization. The eggs from unimmunized chicken
were also collected as a normal control. The IgY anti-
body was purified from egg yolk by water-dilution and
ammonium sulfate precipitation method. The egg white
and egg yolk membrane were removed after breaking
the eggs; the egg yolk was diluted with 9 volumes of dis-
tilled water, and mixed by stirring fully. The pH value of
the solution was adjusted to 5.1-5.4 with HCl and stored
at 4°C over night. The supernatant was filtered through
the filter papers, and then centrifuged at 10000 rpm for
10 min at 4°C. The crude extraction suspension was
mixed with 50% (V/V) saturated ammonium sulfate so-
lution and stirred at 4°C for 2 h. After centrifugation,
the precipitate was collected and dissolved in 0.01 M
phosphate buffered saline (PBS, pH 7.4). The solution
was re-precipitated by adding 33% (V/V) saturated am-
monium sulfate. The precipitate was dissolved in PBS in
an equal volume to the original egg yolk volume and
dialyzed against distilled water, and then PBS to remove
the NH4+ [41-43].
Protein content of purified IgY was checked by Brad-
ford protein assay kit (TIANGEN, China). The same
amount of IgY proteins before and after purification
were analyzed by SDS-PAGE. The gels were stained by
Coomassie brilliant blue to observe the protein bands.
The antibody titer was estimated by indirect ELISA.
The Nunc-Immuno plates (MaxiSorp F96, Thermo,
USA) were coated with 0.125 μg AWA per well in
0.06 M carbonate coating buffer (pH 9.6) and stored
overnight at 4°C. After washing three times with PBS
containing 0.1% Tween 20, the plates were blocked with
1% BSA diluted in PBS overnight at 4°C. The purified
IgY samples were diluted to 1:400, 1:800, etc. until
1:20480, then, 100μl was dispensed per well in duplicate
onto the plates. The IgY from unimmunized egg yolk
was used as negative control. The plates were incubated
at 37°C for 2 h. The peroxidase-conjugated rabbit anti-
chicken secondary antibody (Sigma, USA) was used at a
1:20000 dilution and the plates were incubated at 37°C
for 1 h. The substrate, 3, 3′, 5, 5′-tetramethylbenzidine(TMB, TIANGEN, China) was used for the assay. The
optical density (OD) was measured at 450 nm on a
microplate reader (Model 680 XR, Bio-Rad) [42].
Western blotting was employed to evaluate the immu-
noreactivity of IgY. Briefly, the equal amounts of AWA
were separated in 10% SDS-PAGE and then transferred
onto a 0.45 μm nitrocellulose membrane (Amersham
Biosciences-GE Healthcare, USA) at 0.22 A for 1.5 h. After
blocking with 3% BSA diluted in PBS overnight at room
temperature (RT), the membrane was cut as vertical strips
of 4 mm wide and individually treated for 2 h at RT with
IgY from immunized or unimmunized egg yolk at a dilution
of 1:400. The strips were washed at least three times in PBS
containing 0.1% Tween 20 then incubated with peroxidase-
conjugated rabbit anti-chicken secondary antibody (Sigma,
USA) diluted 1:2000 for 1 h at RT. After washing, the sub-
strate 3, 3′-Diaminobenzidine (DAB, Sigma, USA) was
added to develop the color reaction [44,45].
Direct immunoprecipitation
Ten serum samples of schistosomiasis patients and nor-
mal human sera were randomly selected from a sera
bank of National Institute of Parasitic Diseases (NIPD),
China CDC. The serum samples of patients were col-
lected from the endemic areas in Jiangxi provinces, P.R.
China. The diagnosis was made by the Kato-Katz
method for schistosome eggs in the feces. Nine slides
were prepared from three consecutive stool samples and
each slide was examined blind by two trained techni-
cians. The results were recorded as eggs per gram feces
(EPG) and the EPG of ten patients were among 11–283.
The patients included two women and eight men, with
ages ranging from 12 to 59 (Additional file 1: Table S1).
The normal sera were collected from healthy people
living in Shanghai who had never traveled to schisto-
somiasis endemic areas.
The CAs were enriched using sera of schistosomiasis
patients according to the protocol of Pierce Direct IP Kit
(Thermo, USA), and the sera from healthy individuals were
used as a negative control. The enrichment was carried out
by incubation of 100 μl of the AminoLink Plus Coupling
Resin slurry with 50 μg purified antibody at RT for 120
minutes. The pure IgY from immunized egg yolk was
immobilized onto the aldehyde-activated beaded agarose
resin. 1 ml of pooled positive sera (10 individual serum
samples were pooled) was added to the antibody-coupled
resin in a spin column, the column was incubated with
gentle shaking for 1 h at 4°C, to form the antibody-antigen
complex. The complex was washed five times with tris-
buffered saline (TBS) to remove non-bound material and
then eluted with 50μl elution buffer (pH 2.8) to dissociate
the bound antigen from the antibody. The target proteins
were analyzed by 12% SDS-PAGE. Meanwhile, a control
immunoprecipitation was done by using the IgY from
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plied to concentrate the proteins before mass spectrometry.
Mass spectrometry analyses of the antigens
The protein mixtures were denatured in the loading buf-
fer for SDS-PAGE and separated by one-dimensional
electrophoresis. The target lane of the gel was cut
equally into ten slices; the size of a slice was about
5 × 5 mm and numbered 1–10 from the top to the bot-
tom. Each slice was minced into 1 × 1 mm size pieces
and subsequently subjected to in-gel digestion with
modified trypsin (Roche) according to standard proce-
dures. Peptides were extracted by sonication with 50%
ACN, 5%FA in ddH2O. Finally, the extracted tryptic
digests were concentrated in a speedvac to a final vol-
ume of ~10μl prior to mass spectrometric analysis. After
pre-preparation, the peptide mixtures from the gel slices
were analyzed by LC-MS/MS as previously described
[38,46,47] . In brief, the tryptic digests were then loaded
onto a reverse phase (RP) trap column (C18, 5 μm,
300 Å, 300 mm id × 5 mm, Waters) for enrichment at a
flow rate of 10 μl/min. The trap column was sequentially
connected in-line with an analytical 75 μm×150 mm
C18 column (Waters) and the peptide mixtures were
eluted into SYNAPT G2 (Waters) at a flow rate of
200 nl/min. NanoUPLC (Waters) was used to deliver
mobile phases A (0.5% acetic acid in water) and B (0.5%
acetic acid in ACN) at a linear gradient from 5% B to
50% B within 60 min, along with a gradient from 50% B
to 90% B within 30 min and then 90% B for 15 min. A
spray voltage of 3200 V was applied to a 10 μm id Pico-
Tip nanospray emitter (New Objective) connected at the
end of the analytical column through a stainless union
joint (Valco Instrument) to give a steady spray.
The data were post acquisition lock mass corrected
using the doubly charged monoisotopic ion of [Glu1]-
fibrinopeptide B. The reference sprayer was sampled
with a frequency of 30 s. Accurate mass LC-MS data
were collected in an alternating, low energy, and
elevated-energy mode of acquisition. The spectral acqui-
sition time in each mode was 0.9 s. In low energy MS
mode, data were collected at constant collision energy of
4 eV. In elevated-energy MS mode, the collision energy
was ramped from 15 to 55 eV during each 0.9 s integra-
tion. One cycle of low and elevated-energy data was
acquired every 1.84 s.The scan window was set from m/
z 100 to 1800.
The LC-MS/MS spectra were searched against the S.
japonicum protein databases using MASCOT software
(hettp://www.matrixscience.com, Matrix Science) as pre-
viously described [38,46]. To determine whether these
peptides originated from the schistosome or the host,
the MSE DATA were searched against the human pro-
tein databases (IPI, HUMAN, V3.72) using PLGS 2.4(Waters). Searching parameters as follows: the Value of
Min Fragment Ion Matches per Peptide was 3, the Value
of Min Fragment Ion Matches per Protein was 7, and
the Value of Min Peptide Matches per Protein 1; Trypsin
was set as digest reagent, the allowed number of Missed
Cleavages was 2; Carbamidomethyl C was set as fixed
modification, Oxidation M and Phosphoryl STY were
set as variable modifications. The False Positive Rate was
less than 1%. The peptides identified were also compared
with the protein sequences of schistosome and human
by using the BLAST program.
Results
Preparation of the worm antigen
The parasites were collected from the infected rabbits,
and used to prepare the adult worm antigen (AWA). Fi-
nally, the homogenate antigen solution, which contains
the total soluble proteins and insoluble proteins of adult
worm, were obtained. The concentration of the crude
solution was 10.8 mg/ml by Bradford protein assay.
Analysis of IgY
We used the water dilution method to obtain a super-
natant with crude egg yolk antibody (water-soluble frac-
tion, WSF), and then the IgY was precipitated by
ammonium sulfate with better purity. The concentration
of purified IgY was 7.44 mg/ml. From each immunized
egg yolk, about 75 mg of IgY was extracted. IgY is a big
biological molecule with a molecular weight of 180 kDa
and consists of two larger subunits and two smaller sub-
units. The molecular weights of the larger subunits and
smaller subunits were about 66 kDa and 30 kDa respect-
ively. Under reducing conditions, the disulfide bond
could be broken down, resulting in the separation of lar-
ger subunits and smaller subunits. SDS-PAGE analysis
showed two protein bands, the heavy chain was 62 kDa
and the light chain was 37 kDa.
After immunization and purification, the titer of IgY
was 1:12800. Equivalent amounts of AWA were loaded
onto the different lanes of the gels. One gel was used for
a Western blotting assay and the other gel was stained
by Coomassie brilliant blue as a control. The results of
Western blotting showed that different protein bands in
AWA could be recognized by the IgY from immunized
egg yolk and no specific band was recognized by the IgY
from the unimmunized egg yolk (Figure 1).
Direct immunoprecipitation
The circulating antigens were immune-precipitated from
serum samples by using the Thermo Scientific Pierce
Direct IP Kit. Firstly, IgY was immobilized on the beads,
the sera were incubated with antibody-binding resin on
the spin column. The antigens were eluted from the













1          2       Marker                    3         4     Marker A B
Figure 1 Evaluation the immunoreactivity of IgY by Western blotting using the AWA. Marker: protein size standard, 1and 2: The AWA,
3: IgY from immunized egg yolk, 4: IgY from unimmunized egg yolk. A: The staining gel of AWA. Equivalent amounts of AWA have been loaded
on the different lanes of the gels for Western blotting and staining by Coomassie brilliant blue as a control. B: Western blotting analysis of IgY.
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several protein bands with different molecular weights
could be immunoprecipitated from the patients′ sera,
while only nonspecific protein bands could be immuno-
precipitated from healthy peoples′ sera. By using IgY
from unimmunized egg yolk, the same nonspecific bands
were observed both in patients′ sera and healthy per-
sons′ sera (Figure 2). The proteins precipitated from
patients′ sera by the anti-AWA IgY were expected as
circulating antigens. The proteins were concentrated
with the final concentration of 0.27 mg/mL for the fol-
lowing MS analysis.
Marker: protein size standard, 1: IgY, 2: Flow-through
after antibody coupling, 3: Flow-through after immuno-
precipitation from patients′ sera, 4: Flow-through after
immunoprecipitation from healthy peoples′ sera, 5: Eluate
from patients′ sera, 6: Eluate from healthy peoples′ sera.
A: Immunoprecipitation of the circulating antigens by
using IgY from immunized egg yolk. B: Immunoprecipita-
tion of the circulating antigens by using IgY from unim-
munized egg yolk.
Identification of the circulating antigens by mass
spectrometry
S. japonicum circulating antigens were analyzed by LC-MS
/MS followed by forward and reverse database searching
and BLAST program. We characterized four S. japonicum
proteins from the gel bands (Table 1, Additional file 2:
Table S2) as S. japonicum circulating antigens, including
protein BUD31 homolog (CAX70049.1), ribonuclease
(CAX70531.1), SJCHGC06971 protein (AAX28592.2) and
SJCHGC04754 protein (AAX28446.2). The molecularweights of four proteins ranged from 10 to 22 kDa. The
SJCHGC06971 protein and SJCHGC04754 protein were
identified from the eighth slice, protein BUD31 homolog
was identified from the ninth slice and the ribonuclease
was identified from the tenth slice.
Discussion
Advanced diagnosis for the disease plays a crucial role in
the control of schistosomiasis, especially when the trans-
mission levels are not very high. Detection of circulating
antigens is one of the most accurate diagnostic methods
for distinguishing between the active or past infection
and for evaluation of the chemotherapy efficiency.
Apart from the CAA and CCA, little else is known
about schistosome antigens in the circulation. In this
study, we established a new method for profiling the
CAs of S. japonicum by direct immunoprecipitation
based on IgY and mass spectrometry. It is the first report
on profiling CAs which schistosomes have excreted into
the sera. Compared to the mammalian antibodies, IgY
had a higher specificity, sensitivity and stability [29-32].
The IgY against AWA was used as the capture antibody
to enrich the CAs through immunoprecipitation in our
research. Immunoprecipitation could be used to isolate
and concentrate a particular protein from a sample con-
taining thousands of different proteins. In contrast to
the traditional methods, the Direct IP Kit used an
amine-reactive support that does not contain Protein A
or Protein G and did not need a cross linker for covalent
immobilization. Furthermore, this method could couple
any primary amine-containing molecule, unlike the
other methods requiring certain species and subclass of














Figure 2 Immunoprecipitation of the circulating antigens. The
circulating antigens were precipitated by the anti-AWA IgY. SDS-
PAGE was used to analyze the immunoprecipitated proteins.
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G. The antibody was irreversibly attached to the agarose
beads so that co-elution of heavy and light chains with
the purified protein is minimized. Only antigens were
eluted by the procedure, enabling them to be identified
and further analyzed without interference from antibody
fragments.
Moreover, Deelder’s group analyzed the composition
of CAA and CCA years ago. The results indicated that
CCA is O-glycosylated mostly via GalNAc-Thr and CAA
is a glycoprotein, O-glycosylated at Thr. The major
carbohydrate fraction of CCA comprised a population of
polysaccharides, containing Lewis x repeating units (−3)
Gal beta (1–4) [Fuc alpha (1–3)] GlcNAc beta (1-) [48].
While the major carbohydrate chains of CAA had a
novel polysaccharide structure, consisting of a branched
disaccharide repeating unit containing 2-acetamido-2Table 1 Proteins in sera of S. japonicum patients identified by
Accession no. Annotation mw(Da)
CAX70049.1 Protein BUD31 homolog 16962
CAX70531.1 ribonuclease 10766
AAX28592.2 SJCHGC06971 protein 20168
AAX28446.2 SJCHGC04754 protein 21607-deoxy-beta-D- galactopyranose (beta-D-Galp-NAc) and
beta-D-glucopyranuronic acid (beta-D-GlcpA) [49].
However, we analyzed the glycosylation sites for these
four proteins by online tools (https://www.predictpro-
tein.org/, http://www.cbs.dtu.dk/services/) and found no
O-glycosylation sites among them (Data not shown
here). The result implied that the four proteins may be
new CAs except CAA and CCA.
Among the four proteins, protein BUD31 homolog
shared 99% (143/144) identity with g10 protein homolog
of S. mansoni. Protein BUD31 and G10 protein were
members of G10 superfamily. The G10 family was
involved in transcription/cell division and chromosome
partitioning. The conserved domain BUD 31 was related
to cell cycle control. Protein BUD 31 had been found in
multiple splicing related protein complexes [50,51].
The ribonuclease of S. japonicum (CAX70531.1)
showed 98% (96/98) identity with S. mansoni ribonucle-
ase (XP002581286.1). However, the alignment of this
ribonuclease (CAX70531.1) revealed a very low identity
(<15%) with the omega-1 (ABB73002.1, S. mansoni),
which had previously been identified as a hepatotoxic
ribonuclease [52].Omega-1was a 31 kDa monomeric
glycoprotein with an isoelectric point (pI) of greater than
9 released from S. mansoni eggs [52,53]. The result of
ELISA with sera from mice and humans infected with
different schistosome species showed that omega-1 was
specific to S. mansoni [52]. Omega-1 was capable of
conditioning human monocyte-derived dendritic cells
(DCs) in vitro to drive T helper 2 (Th2) polarizations
with similar characteristics as whole SEA [54]. Omega-1
also affected the adherence properties and morphology
of DCs and omega-1-exposed DCs displayed pro-
nounced cytoskeletal changes and exhibited decreased
antigen-dependent conjugate formation with CD4+ T
cells [55]. Since the ribonuclease in this paper is a 98-
amino acid protein with a molecular weight of 11 kDa
and a pI of 6, the protein might represent a new ribo-
nuclease of schistosomes.
The SJCHGC06971 protein shared 65% identity with
S. mansoni centaurin/arf-related. The SJCHGC04754
protein belonged to the AAT-I Superfamily and showed
55% identity with Ascaris suum aromatic L-amino-acid
decarboxylase (AADC). AADC, which was responsible
for the biosynthesis of serotonin in mammalian systems,LC-MS/MS
pI PLGS score Peptides Coverage
8.9205 733.3332 9 30.5556
6.0502 579.0666 2 61.2245
8.0665 419.5011 5 43.956
5.2317 290.0222 2 7.3298
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of adult female A. suum [56].
Although there are some previous reports about Pro-
tein BUD31 and ribonuclease, the potential values for
the diagnosis are still being defined. SJCHGC06971 pro-
tein and SJCHGC04754 protein had no annotation and
had not been characterized in the adult worm of schisto-
somes. Furthermore, the four proteins in this paper or the
S. mansoni homologues had not been reported from the
proteomic analysis of S.mansoni egg secretions, the schisto-
some tegumental proteins, adult S. mansoni gut contents
and excretory/secretory proteins of adult S. japonicum
worms [38,57-60]. More work is needed for the further
study of these proteins.
Identification of all the CAs components was import-
ant for understanding how schistosomes interact with
the host. It is believed that the information provided in
this study may facilitate the development of new diag-
nostic antigens for schistosomiasis control.
Detection of CAs secreted by living parasites was a desir-
able way to differentiate between active and past infections;
however, suitable circulating antigens for this purpose
remained unavailable. On the other hand, the natural anti-
gens were difficult to isolate in large amounts. The develop-
ment of genetic-engineering techniques has allowed the
production of recombinant antigens in sufficient quantities
for large-scale testing. Pure or single-molecule antigen
might also improve the specificity of immunodiagnostic
tests. Future studies will aim at finding high-abundance cir-
culating antigens, which will be cloned and expressed.
Preparation of monoclonal antibodies (mAbs) to the re-
combinant antigens, then the IgY and mAbs will be applied
for antigen detection through the double sandwich ELISA.
Such investigations should offer new perspectives on diag-
nosis of schistosomiasis or evaluation of the efficacy of
chemotherapy.
Conclusions
Circulating antigens could be used for distinguishing the
active or past schistosome infection, as well as for evalu-
ation of the chemotherapy efficacy. In this study, we devel-
oped a novel method for identification and profiling CAs in
sera of S. japonicum infected patients. This method based
on IgY, direct immunoprecipitation and LC-MS/MS. Four
new CAs, which have potential value for further develop-
ment of an antigen assay, were identified. It was the first re-
port on profiling CAs of S. japonicum and the results were
helpful to find new diagnostic antigens for assessing active
infections and evaluating the efficacy of treatments.
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